|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> >> 市场分析报告 |
市场分析报告 |
|
Obesity - Pipeline Insight, 2021 ... of development for the treatment of obesity. Danuglipron: Pfizer Danuglipron (formerly PF 06882961) is an orally administered ... Therapeutics NovmetaPharma Key Products Tirzepatide Danuglipron Noiiglutide MEDI 0382 Namodenoson NN 9838 ... Formulation Development Outsourcing Market Report by Service (Pre-formulation Services, Formulation Optimization), Dosage Form (Injectable, Oral, Topical, and Others), Application (Oncology, Genetic Disorders, Neurology, Infectious Diseases, Respiratory, Cardiovascular, and Others), End User (Pharmaceutical and Biopharmaceutical Companies, Government and Academic Institutes), and Region 2025-2033 ... -daily modified-release formulation for danuglipron, an oral glucagon-like peptide-1 (GLP ... |